1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
URL Address
<a href="http://doi.org/10.1097/YIC.0000000000000269" target="_blank" rel="noreferrer noopener">http://doi.org/10.1097/YIC.0000000000000269</a>
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Addressing clozapine under-prescribing and barriers to initiation: a psychiatrist, advanced practice provider, and trainee survey
Publisher
An entity responsible for making the resource available
International Clinical Psychopharmacology
Date
A point or period of time associated with an event in the lifecycle of the resource
2019
2019-05
Creator
An entity primarily responsible for making the resource
Leung Jonathan G; Cusimano Joseph; Gannon Jessica M; Milgrom Olga; Valcourt Stephanie C; Stoklosa Joseph B; Kemp Michael; Olsufka William; Vickery P Brittany; Nichols Stephanie D; Crouse Ericka L; Paxos Chris; Johnson Emily K; Palmer Brian A
Description
An account of the resource
Clozapine use has declined, despite its superior antipsychotic efficacy in treatment-resistant schizophrenia. Implications for clozapine underutilization include suboptimal treatment outcomes and increased hospitalizations. Many barriers preventing the use of clozapine have been described in the literature, including suboptimal knowledge and poor perceptions. The aim of this study was to assess psychiatry prescribers' perception and knowledge of clozapine. A survey was distributed to advanced practice providers, psychiatrists, and trainees (i.e. residents and fellows) at 10 medical centers within the US and Canada. The survey asked respondents about their perception of clozapine use and assessed their pharmacotherapeutic knowledge of clozapine. Two hundred eleven individual submitted completed surveys of a possible 1152; a response rate of 18.3%. There were no statistically significant differences between the advanced practice provider plus psychiatrist groups and the trainee group for most perception (eight of nine) and knowledge (eight of nine) questions. The knowledge questions with the lowest scores pertained to clozapine reinitiation and myocarditis. The majority of all respondents (144, 68.2%) felt that clozapine prescribing was a burden. Findings of this study support the need for continued clozapine education regardless of a prescriber's age/experience. Future studies to assess barriers to clozapine prescribing should extend beyond academic centers.
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1097/YIC.0000000000000269" target="_blank" rel="noreferrer noopener">10.1097/YIC.0000000000000269</a>
2019
Crouse Ericka L
Cusimano Joseph
Department of Pharmacy Practice
Gannon Jessica M
International Clinical Psychopharmacology
Johnson Emily K
June 2019 Update
Kemp Michael
Leung Jonathan G
Milgrom Olga
NEOMED College of Pharmacy
Nichols Stephanie D
Olsufka William
Palmer Brian A
Paxos Chris
Stoklosa Joseph B
Valcourt Stephanie C
Vickery P Brittany